Table 2 Demographic and clinical characteristics (N = 75).
Variables | Categories | N (%), median (25–75 percentile) |
|---|---|---|
Sex | Male | 52 (69.3) |
Female | 23 (30.7) | |
Age (years) | 72.0 (64.0–78.0) | |
Body mass index (kg/m2) | 20.4 (18.6–23.6) | |
Brinkman index | 0.0 (0.0–440.0) | |
Alcohol consumption | Regular drinker | 34 (45.3) |
Social drinker | 7 (9.3) | |
None | 34 (45.3) | |
Number of teeth | 16.0 (3.0–24.0) | |
Systemic disease (yes) | Diabetes mellitus | 17 (22.7) |
Hypertension | 27 (36.0) | |
Cardiovascular disease | 8 (10.7) | |
Cerebrovascular disease | 5 (6.7) | |
Liver disease | 4 (5.3) | |
Pulmonary disease | 8 (10.7) | |
Kidney disease | 5 (6.7) | |
Orthopedic disease | 8 (10.7) | |
Psychiatric disease | 6 (8.0) | |
Cancer (except oral cancer) | 6 (8.0) | |
Performance status | 0 | 59 (78.7) |
1 | 9 (12.0) | |
2 | 1 (1.3) | |
3 | 6 (8.0) | |
Primary tumor site | Tongue | 31 (41.3) |
Upper gingiva | 16 (21.3) | |
Lower gingiva | 14 (18.7) | |
Palate | 3 (4.0) | |
Oral floor | 5 (6.7) | |
Buccal mucosa | 3 (4.0) | |
Intraosseous of mandible | 2 (2.7) | |
Lip | 1 (1.3) | |
Tumor stage | Stage I | 17 (22.7) |
Stage II | 9 (12.0) | |
Stage III | 12 (16.0) | |
Stage IV | 37 (49.3) | |
Treatment | Surgery | 40 (53.3) |
Surgery + radiotherapy | 10 (13.3) | |
Surgery + chemoradiotherapy | 25 (33.3) | |
Neck dissection (yes) | 48 (64.0) | |
Reconstruction (yes) | 47 (62.7) | |
Oral function mesurement | Microorganisms (grade) | 3.0 (2.0–5.0) |
Oral dryness | 24.8 (21.3–26.7) | |
Occulusal force (N) | 245.6 (18.0–443.6) | |
Tongue pressure (kPa) | 17.1 (7.5–23.6) | |
Masticatory function (mg/dL) | 75.0 (15.0–150.0) | |
EAT-10 | 15.0 (4.0–25.0) | |
Functional oral intake scale | 1 | 6 (8.0) |
2 | 4 (5.3) | |
3 | 0 (0.0) | |
4 | 8 (10.7) | |
5 | 22 (29.3) | |
6 | 25 (33.3) | |
7 | 10 (13.3) | |
MNA-SF | Total score | 9.0 (7.0–11.0) |
Normal nutritional status | 16 (21.3) | |
At risk of malnutrition | 31 (41.3) | |
Malnourished | 28 (37.3) |
